Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters

被引:94
作者
Takeda, M [1 ]
Narikawa, S [1 ]
Hosoyamada, M [1 ]
Cha, SH [1 ]
Sekine, T [1 ]
Endou, H [1 ]
机构
[1] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan
关键词
organic anion transporter; inhibitor; proximal tubule; betamipron; cilastatin; KW-3902; probenecid;
D O I
10.1016/S0014-2999(01)00962-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The organic anion transport system is involved in the tubular excretion of various clinically important drugs. The purpose of this study was to characterize the effects of various organic anion transport inhibitors on organic anion transport using proximal tubule cells stably expressing human organic anion transporter I (human-OAT1) anal human-OAT3, which are localized to the basolateral membrane of the proximal tubule. Organic anion transport inhibitors including betamipron, cilastatin, KW-3901 (8-(noradamantan-3-yl)-1,3-dipropylxanthine) and probenecid significantly inhibited human-OAT1- and human-OAT3-mediated organic anion uptake in a dose-dependent manner. Kinetic analyses revealed that these inhibitions were competitive. The K-i values of betamipron, cilastatin, KW-3902 and probencid for human-OAT1 were 23.6, 1470, 7.82 and 12.1 muM, whereas those for human-OAT3 were 48.3, 231, 3.70 and 9.0 muM. These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one. In contrast, KW-3902 did not exert the effects of significance, whereas KW-3902 was the most potent. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 39 条
[1]   Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2 [J].
Abe, T ;
Kakyo, M ;
Sakagami, H ;
Tokui, T ;
Nishio, T ;
Tanemoto, M ;
Nomura, H ;
Hebert, SC ;
Matsuno, S ;
Kondo, H ;
Yawo, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22395-22401
[2]  
Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847
[3]  
BASIN KS, 1991, J RHEUMATOL, V18, P609
[4]  
BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X
[5]   Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta [J].
Cha, SH ;
Sekine, T ;
Kusuhara, H ;
Yu, E ;
Kim, JY ;
Kim, DK ;
Sugiyama, Y ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :4507-4512
[6]  
CHA SK, IN PRESS MOL PHARM
[7]   The pharmacology of meropenem, a new carbapenem antibiotic [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S266-S275
[8]   PREVENTIVE EFFECT OF BETAMIPRON ON NEPHROTOXICITY AND UPTAKE OF CARBAPENEMS IN RABBIT RENAL-CORTEX [J].
HIROUCHI, Y ;
NAGANUMA, H ;
KAWAHARA, Y ;
OKADA, R ;
KAMIYA, A ;
INUI, K ;
HORI, R .
JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 66 (01) :1-6
[9]   Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene [J].
Hosoyamada, M ;
Obinata, M ;
Suzuki, M ;
Endou, H .
ARCHIVES OF TOXICOLOGY, 1996, 70 (05) :284-292
[10]   Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney [J].
Hosoyamada, M ;
Sekine, T ;
Kanai, Y ;
Endou, H .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 276 (01) :F122-F128